Virtual reality/Spain
They sent the headset home with the patient, and only the fear score moved
A Barcelona trial sent standalone VR headsets home with ACL patients. Fear of movement fell significantly. Strength, range of motion and disability did not.
In what the authors describe as the first clinical study of independent home use of therapeutic virtual reality after orthopaedic surgery, 47 patients undergoing ACL reconstruction were randomised to conventional rehabilitation with or without 20 minutes of daily VR. Kinesiophobia was significantly lower at four weeks, 27.00 against 33.35 with a Cohen's d of -0.971. Self-reported disability, strength and range of motion showed no significant differences.
What happened
Anterior cruciate ligament reconstruction is common, particularly among young athletes, and the surgery is the easy part. Rehabilitation is long, re-injury rates are high, and recovery is held back by two things that are not mechanical: muscle inhibition and fear of moving the knee.
Researchers at the Institut d’Investigacions Biomediques August Pi i Sunyer and the Faculty of Psychology at the University of Barcelona built a virtual reality programme around those psychological obstacles. Patients were embodied in a virtual body, seen from a first-person perspective, and performed exercises guided by a virtual physiotherapist.
Then they did something that, as far as the authors know, nobody had done before in this setting: they sent the headset home. Patients ran the twenty-minute daily programme themselves on a standalone head-mounted display, for four weeks after surgery, with no therapist in the room.
Fear of movement dropped significantly. Nothing else did.
The test
Parallel randomised controlled trial. 47 participants were randomised to conventional rehabilitation alone or conventional rehabilitation plus the home VR programme; 44 completed treatment.
The VR content incorporated several elements the group had developed from their embodiment research: a virtual body, first-person perspective, and virtual exercises guided by an on-screen physiotherapist. Patients visualised, planned and executed movements through the avatar.
Outcomes were measured at baseline, 4, 12 and 36 weeks: self-reported disability on the International Knee Documentation Committee score, quadriceps strength limb symmetry, active knee extension range of motion limb symmetry, and kinesiophobia on the short-form Tampa Scale.
Thirty-six weeks of follow-up is longer than most digital rehabilitation trials manage.
The numbers
| Measure | Finding |
|---|---|
| Randomised / completed | 47 / 44 |
| VR dose | 20 minutes daily, 4 weeks, unsupervised at home |
| Kinesiophobia at 4 weeks, VR | 27.00 +/- 6.58 |
| Kinesiophobia at 4 weeks, control | 33.35 +/- 5.07 |
| Effect size, kinesiophobia | Cohen’s d -0.971, p = 0.045 |
| IKDC disability | not statistically significant |
| IKDC effect sizes | d = 0.559 at 4 weeks, d = 0.722 at 36 weeks |
| Strength and range of motion symmetry | no significant difference |
| Adverse events | none related to the intervention |
| Registration | NCT05080894, registered 20 September 2021 |
The result
Both groups improved significantly on all outcomes over time, at p below 0.001, which is what rehabilitation after ACL reconstruction does.
Between groups, the VR arm showed significantly lower kinesiophobia at four weeks: 27.00 against 33.35, with a Cohen’s d of -0.971 at p = 0.045. That is a large effect size sitting on a marginal p-value, which is characteristic of a real effect in a small sample.
The International Knee Documentation Committee score – the primary measure of self-reported knee function – was not statistically significantly different, despite moderate effect sizes of 0.559 at four weeks and 0.722 at 36 weeks.
Quadriceps strength limb symmetry and active knee extension range of motion symmetry showed no differences.
No adverse events related to the intervention were reported.
How this compares to what came before
Therapeutic VR studies almost always run in a clinic with a therapist present. That controls the dose and guarantees safety, and it also means the studies cannot tell you whether the technology works when nobody is watching – which is the deployment that would actually scale.
The authors state this is, to their knowledge, the first clinical study to investigate the independent use of therapeutic VR at home during post-orthopaedic surgery rehabilitation.
That makes the safety result as important as the efficacy one. Forty-seven patients used a head-mounted display unsupervised, four weeks after knee surgery, with no intervention-related adverse events.
The kinesiophobia result also sits alongside a Chinese trial in this same batch, where dose-matched VR after rotator cuff repair produced a significant kinesiophobia improvement and nothing else. Two independent trials, different joints, different countries, different VR content, same pattern: the psychological outcome moves and the physical ones do not.
What it means
The convergence is the interesting part. When two separate randomised trials find the same specific effect, in the same direction, on the same construct, while failing to find effects on physical measures, that is a stronger signal than either trial alone.
Fear of movement is a legitimate target. It predicts poorer return to sport and higher re-injury risk after ACL reconstruction, and it is difficult to address with conventional physiotherapy.
Where this trial goes further than the rotator cuff one is in the delivery model. Twenty minutes a day at home, unsupervised, on a standalone device is a format that a health system could actually afford to deploy. Clinic-based VR requires a room, a device and a therapist; home VR requires a device.
The honest caveat is that the knee function result is unresolved rather than negative. Effect sizes of 0.559 and 0.722 with 44 completers are what you see when a trial is too small, not when there is nothing there.
Business ideas from this paper
Home rehabilitation VR as a prescribed device. The delivery model tested here – standalone headset, twenty minutes daily, no supervision – is the one that scales. Building the logistics around it, including device despatch, cleaning and return, is an operations business.
Kinesiophobia-targeted content. Two independent trials now point at fear of movement as the outcome VR moves. Content designed specifically for graded exposure and confidence, rather than general exercise, has a clearer mechanism and a clearer claim.
Adherence telemetry. Unsupervised home use raises an obvious question nobody answered here: did patients actually do their twenty minutes? A headset that reports session completion turns a hope into a measurement, and payers will want it.
Return-to-sport risk stratification. If kinesiophobia predicts re-injury and VR reduces kinesiophobia, the commercial link runs through sports medicine and insurance. Quantifying that chain is a research programme with a paying customer.
What could be wrong with it
47 randomised and 44 completing is small for a trial with four outcomes at four time points.
The headline kinesiophobia result sits at p = 0.045, close enough to the threshold to be fragile, in a trial testing multiple outcomes.
The primary knee function measure was not significant, and anyone reading this as evidence that home VR improves knee outcomes is reading past the result.
Patients cannot be blinded to whether they have a headset at home, and the outcome that moved was self-reported.
Data are not openly available, cited as sensitive and available from the corresponding author.
Adherence to the twenty minutes a day is not reported in what we could verify, which for an unsupervised intervention is the number that determines what was actually tested.
How sure can you be?
We score this 8 out of 10.
It is a peer-reviewed parallel randomised controlled trial in the Journal of Orthopaedic Surgery and Research, pre-registered on ClinicalTrials.gov in 2021 before recruitment, with 36-week follow-up and two named institutions in Barcelona – IDIBAPS and the Faculty of Psychology at the University of Barcelona.
It loses points for the single centre and the absence of open data.
The safety finding for unsupervised home use we would report with confidence. The kinesiophobia finding we would report as consistent with an independent trial in another joint. The knee function finding we would report as unresolved.
Do this today
If you run ACL rehabilitation, measure kinesiophobia. It takes two minutes with the Tampa Scale, it predicts outcomes, and two randomised trials now suggest it is the thing most responsive to a VR intervention.
If you are building rehabilitation VR, design for unsupervised home use from the start. That is the deployment model with the economics behind it, and this trial is the first evidence it is safe.
If you are commissioning digital rehabilitation, ask for adherence data alongside outcome data. An unsupervised intervention with unreported adherence leaves you unable to tell a treatment failure from a usage failure.
Source: Decreased kinesiophobia with virtual embodiment for post-surgical knee rehabilitation: a randomized controlled trial, Journal of Orthopaedic Surgery and Research, April 2026. PMID 42036710 · doi.org ().
Just Out Tech explains new research in plain language. This article was drafted with AI assistance and checked by a human against the original source.
- Patients used a standalone head-mounted display at home, unsupervised, for 20 minutes a day over 4 weeks.
- Kinesiophobia was significantly lower at 4 weeks, with a large effect size of -0.971.
- The knee disability score showed no significant difference despite moderate effect sizes at 4 and 36 weeks.
- Strength and range of motion limb symmetry did not differ at all, and no adverse events were reported.
The authors state this is, to their knowledge, the first clinical study investigating independent use of therapeutic VR at home during post-orthopaedic surgery rehabilitation, with patients using a standalone headset without a therapist present.
Questions people ask
What is virtual embodiment?
The VR content put the patient in a virtual body seen from a first-person perspective, so that the exercises were performed by an avatar they identified with, guided by a virtual physiotherapist.
Why does kinesiophobia matter after ACL surgery?
Fear of re-injury is a well-documented obstacle to recovery and return to sport, and it predicts worse outcomes independent of physical healing. Reducing it is a legitimate therapeutic target.
Did the knee get better?
Both groups improved significantly over time. The difference between them on the knee disability score was not statistically significant, though the effect sizes were moderate - 0.559 at four weeks and 0.722 at 36 weeks - which is what an underpowered trial looks like.
Was home use safe?
No adverse events related to the intervention were reported across 47 randomised patients using the headset independently at home.
Mark Alex
Mark Alex is the founder and Managing Director of Real Biz Digital, a technology company operating out of Nairobi since 2018. He works in agentic AI and the Model Context Protocol, AI governance, enterprise software architecture and cybersecurity. He holds an MSc in Mechatronical Engineering from Obuda University in Budapest and a BSc in IT, Forensic Technology and Cybercrime, from USIU-Africa in Nairobi, and has published IEEE conference research on an AI-powered digital twin for greenhouse systems. He is the author of seven books. Between 2020 and 2024 he mentored more than 200 university students and interns in Nairobi. He writes every Just Out Tech article from the original research paper.